Zylox-Tonbridge Medical Technology Co., Ltd. Class H (818) Q2 2026 Earnings Report
DE:818 Q2 2026 EPS Results
- Actual EPS
- EUR 0.07
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.05
DE:818 Q2 2026 Revenue Results
- Actual Revenue
- EUR 80.74M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +39.17%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/20/2026
- Time
- Before Open
- Conference Call
- Thursday, August 20, 2026
DE:818 Upcoming Earnings
Zylox-Tonbridge Medical Technology Co., Ltd. Class H's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:818 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | ―- | 0.05 | ― | ― |
| Aug 20, 2026 | 2026 (Q2) | ―0.07 | 0.05 | 54.05% (+0.03) | |
| Mar 17, 2026 | 2025 (Q4) | ―0.05 | 0.01 | 298.11% (+0.04) | |
| Aug 19, 2025 | 2025 (Q2) | ―0.05 | 0.03 | 74.53% (+0.02) | |
| Mar 20, 2025 | 2024 (Q4) | ―0.01 | -0.02 | 174.65% (+0.03) | |
| Aug 20, 2024 | 2024 (Q2) | ―0.03 | -0.01 | 292.73% (+0.04) | |
| Mar 21, 2024 | 2023 (Q4) | ―-0.02 | -0.03 | 52.67% (+0.02) | |
| Aug 23, 2023 | 2023 (Q2) | ―-0.01 | -0.01 | -37.50% (-0.00) | |
| Mar 29, 2023 | 2022 (Q4) | ―-0.03 | -0.05 | 36.71% (+0.02) | |
| Aug 15, 2022 | 2022 (Q2) | ―-0.01 | -0.04 | 70.37% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
